37 CKD is often present in patients with HF, because CKD, T2D, obesity and adiposity frequently coexist in these patients, particularly in those with HFpEF
The national drug regulation body, Central Drugs Standard Control Organisation (CDSCO), has reportedly authorised the use of the drug, tirzapatide, for treatment of diabetes
These converge to induce serine phosphorylation of IRS-1, which inhibits its tyrosine phosphorylation and subsequent activation of the PI3K-Akt pathway, ultimately hindering GLUT4 translocation and glucose uptake (94, 95)
Patient preferences for oral versus injectable GLP-1RAs need to be further explored in this context
Our in vitro study suggested that mesenchymal stromal cells may protect T-ALL blasts from cytotoxicity induced by pegylated arginase I
It supports mitochondrial function and the biochemical processes that produce ATP the bodys energy currency